Variant report
Variant | esv3339547 |
---|---|
Chromosome Location | chr8:69607698-69609696 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr8:69608129-69608466 | ECC-1 | luminal epithelium: | n/a | chr8:69608351-69608362 |
2 | CEBPB | chr8:69608166-69608540 | HepG2 | liver: | n/a | chr8:69608351-69608362 |
3 | CEBPB | chr8:69608178-69608517 | HepG2 | liver: | n/a | chr8:69608351-69608362 |
4 | CEBPB | chr8:69608167-69608541 | A549 | lung: | n/a | chr8:69608351-69608362 |
5 | CEBPB | chr8:69608107-69608461 | MCF-7 | breast: | n/a | chr8:69608351-69608362 |
6 | CEBPB | chr8:69608145-69608518 | A549 | lung: | n/a | chr8:69608351-69608362 |
7 | CEBPB | chr8:69608142-69608461 | ECC-1 | luminal epithelium: | n/a | chr8:69608351-69608362 |
8 | CEBPB | chr8:69608215-69608446 | HepG2 | liver: | n/a | chr8:69608351-69608362 |
9 | CEBPB | chr8:69608082-69608464 | A549 | lung: | n/a | chr8:69608351-69608362 |
10 | CEBPB | chr8:69608185-69608570 | MCF-7 | breast: | n/a | chr8:69608351-69608362 |
11 | CEBPB | chr8:69608270-69608404 | HepG2 | liver: | n/a | chr8:69608351-69608362 |
12 | CEBPB | chr8:69608160-69608546 | K562 | blood: | n/a | chr8:69608351-69608362 |
13 | CEBPB | chr8:69608158-69608544 | Hela-S3 | cervix: | n/a | chr8:69608351-69608362 |
14 | CEBPB | chr8:69608159-69608547 | H1-hESC | embryonic stem cell: | n/a | chr8:69608351-69608362 |
15 | CEBPB | chr8:69608166-69608547 | IMR90 | lung: | n/a | chr8:69608351-69608362 |
16 | MYC | chr8:69608195-69608440 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | STAT3 | chr8:69609120-69609262 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | USF1 | chr8:69608141-69608464 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | USF1 | chr8:69608190-69608393 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | USF2 | chr8:69608250-69608414 | Hela-S3 | cervix: | n/a | chr8:69608311-69608322 |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNA5SP269 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533132758 | chr8:69608205-69608206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201112108 | chr8:69608293-69608294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566403268 | chr8:69608330-69608331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535538127 | chr8:69608341-69608342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139766531 | chr8:69608349-69608350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568824152 | chr8:69608357-69608358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537480849 | chr8:69608373-69608374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs367764308 | chr8:69608401-69608402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558005217 | chr8:69608424-69608425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565832106 | chr8:69608536-69608537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571626485 | chr8:69608643-69608644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200446222 | chr8:69608649-69608650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534088946 | chr8:69608661-69608662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143973137 | chr8:69608662-69608663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574201780 | chr8:69608783-69608784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181696207 | chr8:69608814-69608815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186797851 | chr8:69608845-69608846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556417690 | chr8:69608889-69608890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115584203 | chr8:69608952-69608953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545440074 | chr8:69608984-69608985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571082544 | chr8:69609030-69609031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372219998 | chr8:69609058-69609059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551991398 | chr8:69609105-69609106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533274812 | chr8:69609116-69609117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536964349 | chr8:69609147-69609148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539563277 | chr8:69609154-69609155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560290084 | chr8:69609244-69609245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190804390 | chr8:69609247-69609248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs55820094 | chr8:69609301-69609302 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs10957445 | chr8:69609314-69609315 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs183359222 | chr8:69609327-69609328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188006950 | chr8:69609334-69609335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571564221 | chr8:69609348-69609349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369881782 | chr8:69609382-69609383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534220758 | chr8:69609383-69609384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554210218 | chr8:69609385-69609386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567834231 | chr8:69609401-69609402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536474905 | chr8:69609414-69609415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs189795411 | chr8:69609415-69609416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182637341 | chr8:69609450-69609451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150502945 | chr8:69609453-69609454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558994516 | chr8:69609465-69609466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546424811 | chr8:69609605-69609606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188159234 | chr8:69609609-69609610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192708309 | chr8:69609640-69609641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560219692 | chr8:69609660-69609661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs529059971 | chr8:69609684-69609685 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Sezary syndrome | 18413736 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
head and neck squamous cell carcinoma | 16715129 | CNVD |
Prostate cancer | 16461572 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
Colorectal cancer | 21645411 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:69608200-69608400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr8:69608200-69608400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr8:69608400-69610000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr8:69609600-69610200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |